MedPath

Evaluation of the effect of melatonin on colistin nephrotoxicity

Phase 2
Recruiting
Conditions
ephrotoxicity.
Acute kidney failure, unspecified
N17.9
Registration Number
IRCT20210110049990N1
Lead Sponsor
Shahid Beheshti University Of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

All patients that admitted to the intensive care unit who are being treated with Colistin

Exclusion Criteria

Patient or legal counsel dissatisfaction
People under 18 years old
People with impaired kidney function and creatinine levels greater than 1.5 mg / d

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
24-hour urine volume. Timepoint: Ten days. Method of measurement: Container for measuring the volume of liquids.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath